Josh David Lauring
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 12
-
- PI3K/AKT/mTOR signaling in cancer 11
- Protein Kinase Regulation and GTPase Signaling 6
- CRISPR and Genetic Engineering 6
- Ubiquitin and proteasome pathways 5
- Cancer-related gene regulation 5
- Protein Degradation and Inhibitors 4
- Co-authors
- Ben Ho Park (18 shared papers)Mark S. Schlissel (3 shared papers)John P. Gustin (10 shared papers)Joseph P. Garay (9 shared papers)Abde M. Abukhdeir (8 shared papers)Kyung Hee Yi (4 shared papers)Antonio C. Wolff (4 shared papers)Hiroyuki Konishi (7 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (6 papers)Clinical Cancer Research (6 papers)Oncotarget (6 papers)Journal of the National Comprehensive Cancer Network (3 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Josh David Lauring
54 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 976
- Oncology 851
- Molecular Biology 1.9k
- Hematology 177
- Pulmonary and Respiratory Medicine 460
Countries citing papers authored by Josh David Lauring
This map shows the geographic impact of Josh David Lauring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh David Lauring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh David Lauring more than expected).
Fields of papers citing papers by Josh David Lauring
This network shows the impact of papers produced by Josh David Lauring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh David Lauring. The network helps show where Josh David Lauring may publish in the future.
Co-authors
The 25 scholars most cited alongside Josh David Lauring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 355 | |
| 2 | 2014 | 341 | |
| 3 | 2016 | 317 | |
| 4 | 2015 | 155 | |
| 5 | 2007 | 136 | |
| 6 | 2009 | 136 | |
| 7 | 2011 | 132 | |
| 8 | 2003 | 126 | |
| 9 | 2013 | 96 | |
| 10 | 2015 | 88 | |
| 11 | 2013 | 87 | |
| 12 | 2007 | 80 | |
| 13 | 2016 | 79 | |
| 14 | 2017 | 77 | |
| 15 | 2007 | 76 | |
| 16 | 2015 | 69 | |
| 17 | 2023 | 58 | |
| 18 | 2012 | 57 | |
| 19 | 1999 | 56 | |
| 20 | 2014 | 54 |
About Josh David Lauring
Josh David Lauring is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 54 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), CRISPR and Genetic Engineering (6 papers), Ubiquitin and proteasome pathways (5 papers), Cancer-related gene regulation (5 papers), Protein Degradation and Inhibitors (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (976 citations), Oncology (851 citations), Molecular Biology (1.9k citations), Hematology (177 citations) and Pulmonary and Respiratory Medicine (460 citations). Josh David Lauring has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Ben Ho Park, Mark S. Schlissel, John P. Gustin, Joseph P. Garay, Abde M. Abukhdeir, Kyung Hee Yi, Antonio C. Wolff, Hiroyuki Konishi, Kaifu Chen and Xiaobing Shi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research, Oncotarget, Journal of the National Comprehensive Cancer Network and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.